Title : Neoadjuvant therapy in breast cancer: can we define its role?

Pub. Date : 2001

PMID : 11346684






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Further, patients with an initial clinical response to CVAP were more likely to show a pathological complete response (pCR) at final assessment when four cycles of CVAP were followed by four of docetaxel than when CVAP was maintained for eight cycles (pCR rate 34% versus 16%). Docetaxel amyloid beta precursor protein Homo sapiens